Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients
Saibal Kar(Bakersfield Heart Hospital), Patrick L. Whitlow(Cleveland Clinic), D. Scott Lim(University of Virginia Health System), Mark Reisman(University of Washington Medical Center), Atif Qasim(University of California, San Francisco), Alfredo Trento(Cedars-Sinai Medical Center), Robert Kipperman(Oklahoma Heart Hospital), Tanvir Bajwa(Aurora Health Care), Laura Mauri(Brigham and Women's Hospital), Samir Kapadia(Cleveland Clinic), Richard W. Smalling(Memorial Hermann), Wesley Pedersen(Minneapolis Heart Institute Foundation), H Hermann(University of Pennsylvania), James Hermiller(St. Vincent Hospital), Ted Feldman(Edwards Lifesciences (United States)), John M. Lasala(Lehigh Valley Hospital-Pocono), Donald D. Glower(Duke University)
Cited by 65
Related Papers
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k